- ►yale.edu [PDF] KA Freedberg, E Losina, MC Weinstein, AD … - The New England journal of medicine, 2001 - nejm.highwire.org Methods We developed a mathematical simulation model of HIV disease, using the
CD4 cell count and HIV RNA level as predictors of the progression of disease.
Outcome measures included life expectancy, life expectancy adjusted for the ... Cited by 310 - Related articles - BL Direct - All 12 versions
- ►sanbi.ac.za [PDF] GK Robbins, V De Gruttola, RW Shafer, LM … - The New England journal of medicine, 2003 - nejm.org From Harvard Medical School (GKR, MSH) and the Harvard School of Public Health
(VDG, LMS) — both in Boston; the Stanford University Medical Center, Stanford,
Calif. (RWS, TCM); Social & Sci- entific Systems, Silver Spring, Md. (SWS); ... Cited by 247 - Related articles - BL Direct - All 11 versions
- ►nejm.org GD Sanders, AM Bayoumi, V Sundaram, SP … - The New England Journal of Medicine (CME), 2005 - cme.nejm.org Results Given a 1 percent prevalence of unidentified HIV infection, screening
increased life expectancy by 5.48 days, or 4.70 quality-adjusted days, at an
estimated cost of $194 per screened patient, for a cost-effectiveness ratio ... Cited by 223 - Related articles - Cached - All 17 versions
- ►nih.gov RW Shafer - Clinical Microbiology Reviews, 2002 - cmr.highwire.org There are 16 approved human immunodeficiency virus type 1 (HIV-1) drugs
belonging to three mechanistic classes: protease inhibitors, nucleoside and
nucleotide reverse transcriptase (RT) inhibitors, and nonnucleoside RT ... Cited by 196 - Related articles - BL Direct - All 12 versions
- ►annals.org [PDF] MC Weinstein, SJ Goldie, E Losina, CJ Cohen … - Annals of internal medicine, 2001 - Am Coll Physicians Background: Genotypic sequencing for drug-resistant strains of HIV can guide the
choice of antiretroviral therapy. Objective: To assess the cost-effectiveness of
genotypic resis- tance testing for patients acquiring drug resistance ... Cited by 183 - Related articles - BL Direct - All 8 versions
M Hennessy, D Kelleher, JP Spiers, M Barry, … - British Journal of Clinical Pharmacology, 2002 - pubmedcentral.nih.gov St John's Wort (SJW) is widely used in the treatment of depression but concerns
have been raised about its potential to interact with other drugs.
Co-administration with SJW has resulted in significant reductions in trough ... Cited by 150 - Related articles - BL Direct - All 11 versions
- ►nih.gov S De Meyer, H Azijn, D Surleraux, D … - Antimicrobial agents and chemotherapy, 2005 - Am Soc Microbiol The purpose of this study was to characterize the antiviral activity,
cytotoxicity, and mechanism of action of TMC114, a novel human immunodeficiency
virus type 1 (HIV-1) protease inhibitor (PI). TMC114 exhibited potent ... Cited by 138 - Related articles - BL Direct - All 13 versions
- ►emory.edu [PDF] RJ Pomerantz, DL Horn - Nature medicine, 2003 - medscape.com In the 20 years since the isolation of HIV-1, modern drug discovery and
development have transformed HIV-1 disease into a treatable, chronic infectious
disease ( Table 1 ), although issues of resistance to current therapy and ... Cited by 133 - Related articles - BL Direct - All 9 versions
PW Hunt, SG Deeks, B Rodriguez, H Valdez, … - Aids, 2003 - journals.lww.com From the a Positive Health Program, San Francisco General Hospital, University
of California, the b Division of General Internal Medicine, Veterans Affairs
Medical Center, San Francisco, California, the c Center for AIDS Research, ... Cited by 112 - Related articles - BL Direct - All 6 versions
C Piketty, L Weiss, F Thomas, AS Mohamed, … - The Journal of infectious diseases, 2001 - UChicago Press Featured in Grist "Another symptom of swine flu: instant amnesia" May 11, 2009
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the
Control of Avian and Swine Influenzas Eileen Thacker and Bruce Janke Read ... Cited by 98 - Related articles - BL Direct - All 5 versions
